Our team


Chief Executive & Trustee

Ken is a clinical haematologist with long experience in treating malignant blood disorders. After training at Otago, in Sydney and Southhampton, in the UK, he worked at the Blood and Cancer Centre at Wellington Hospital for 26 years until 2016. Over recent years he has focused on multiple myeloma and helped establish Wellington Hospital as New Zealand’s leading centre, with specialized myeloma clinics and a major centre for clinical trials. The author of 27 publications in peer reviewed journals, Ken is a member of the American Society of Haematology (ASH) and the European Hematology Association (EHA).

Ken is a past chair of the Myeloma section of the based in Melbourne-based Australasian Leukemia & Lymphoma Group (ALLG), which is the principal trial organization for blood cancers.

Currently Ken is consulting at Wakefield Hospital and the new Bowen Icon Cancer Centre, and is the New Zealand representative on the International Myeloma Working Group, a body of 160 myeloma physicians who meet regularly and publish state-of-the-art journal articles.

He is also currently one of two New Zealand representatives on the Medical Advisory Group for Myeloma Australia which puts out Myeloma Treatment Guidelines.

Barbara Horne


Barbara has had an extensive career in leadership, operational and customer-facing roles in the motor industry and in banking.  She is currently Head of Conduct and Customer Inclusion at BNZ.  Her strong track record in understanding the fundamentals that enable organisations to thrive has been invaluable in helping Myeloma New Zealand move towards achieving its vision.

Barbara’s involvement with myeloma began with her husband’s diagnosis in 2015, leading her to develop a deep understanding of the disease, the treatment pathways, and the huge challenges faced by patients and their families. 

Dr David Simpson 


Dr David Simpson MBChB, FRACP, FRCPA is a Haematologist, based at North Shore Hospital. His interests are in malignant haematology. He qualified and specialised in Auckland and had postgraduate training in Vancouver and Toronto. He was Assistant Professor of Bone Marrow Transplant and Cell Therapy at Rush Cancer Institute in Chicago. He has first authored a number of journal articles, reviews, and abstracts. He is active in clinical research and been the principal investigator in over 60 trials.

He is an internationally recognized expert in Multiple Myeloma, CLL and Castlemans disease, and is a member of The Castlemans Disease Collaborative Network (CDCN) Scientific Advisory Committee, the Australasian Myeloma Scientific Advisory Group (MSAG). David is also a member of the Pharmacy and Therapeutics Committee at North Shore Hospital and the Tender Subcommittee of PHARMAC. Dr Simpson provides expert commentary for New Zealand’s Lymphoma and Leukaemia Research Review and Multiple Myeloma Research Review.

Dr Henry Chan


Dr Henry Chan BHB, MBChB, FRACP, FRCPA is a New Zealand-trained haematologist with expertise in multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukaemia.

After completing his advanced training in clinical and laboratory haematology, Henry undertook a clinical fellowship at the internationally-renowned Princess Margaret Cancer Centre in Toronto, Canada. Following his return to New Zealand, he has been involved in multiple international and local collaborative research trials. As the recipient of the Rotary Ross Craig Oncology Award, Henry is currently conducting research on myeloma genomics at the University of Auckland. He also serves as honorary senior lecturer at the University, an alternate member of the Australasian Myeloma Scientific Advisory Group, and a member of the Ministry of Health Tumour Streams. Henry has so far co-authored over 20 publications and abstracts.

Joy Wilkie


Joy Wilkie, Ngati Tarawhai and Ngai Te Rangi from her mother, Pakeha from her father, was diagnosed with multi-focal plasmacytoma in 2015, at the age of 59. She has amazing support from her son Jack, and her daughter Te Moana, who at 21 gave up a year of her life to care for her mother through chemotherapy and her stem cell transplant. Remission is fantastic for Joy and her children.

Joy is committed to advocating for myeloma patients, for the best possible care and treatment in NZ, as in comparable countries, and to supporting our haematologists who are striving so hard to progress multiple myeloma from an incurable disease to a chronic one.

Brent Anderson


Brent runs a Wellington-based consultancy providing advice on leadership, stakeholder management, governance and risk. He is an experienced trustee and director and held senior management roles in the Department of the Prime Minister and Cabinet, the Ministry of Foreign Affairs and Trade, the Independent Police Conduct Authority and the Ministry of Energy.  

Brent strongly supports the vision for Myeloma New Zealand and is pleased to bring his governance and financial management experience to bear in helping build the organisation and realise its vision.

Gavin Nauschutz


Gavin is a director of GSN Associates Ltd and has a wealth of experience across the financial, energy, public and private sectors providing strategic planning and information technology leadership, coupled with extensive portfolio, programme and projects management experience. His governance experience includes a number of years on the governing body of a school overseas.

Gavin has been involved with multiple myeloma since 2012 and is passionate about improving the treatment, lives and care for myeloma patients and the support for their families and whanau.  Gavin and his wife have two adult children and one grandchild.

Tania Crosbie

Special Projects Manager

Tania works as an independent consultant undertaking projects requiring evidence based writing, including work involving innovative treatments for blood cancers. Prior to this she spent 15 years working in the Pharmaceutical industry in various business and leadership roles.

In 2014 Tania’s husband Paul was diagnosed with myeloma, leading her to gain insights as a carer and provide support in helping Paul and their family understand and navigate the health system. Paul is currently in remission and they are both grateful for the expertise and compassion of the medical experts involved in Paul’s care and hope myeloma patients will have a future with more and improved options for treatment.

Joy Woollett

Executive Assistant

Joy loves working in supporting roles for organisations that improve quality of life for people in New Zealand. Joy has worked in administrative roles including government, not-for-profit health support and community volunteer roles. Joy currently also works in administration and funding roles for not-for-profit organisations who support children and youth in New Zealand.

Joy has an interest in health and well-being and is passionate about supporting Myeloma New Zealand.